The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Utility of the SEER-Medicare Data to Identify Chemotherapy Use
Abstract
BACKGROUND: Medicare claims include codes for chemotherapy administration and specific drugs given, and researchers are increasingly using these data to measure the use of chemotherapy. However, the validity and completeness of these data as a source of information has not been established. OBJECTIVES: This analysis is intended to assess the utility of the Medicare claims to capture chemotherapy use. METHODS: Persons with breast, colorectal, and ovarian cancer were identified from the linked SEER-Medicare data. Their Medicare claims were reviewed to determine if there were any bills for chemotherapy, and if so, if there were claims for specific agents. This information was compared with data on the first course of treatment obtained from hospitals and treating physicians by the SEER registries through an NCI-supported Patterns of Care Studies (POC). Agreement was measured using kappa statistics. The sensitivity of the Medicare claims to capture chemotherapy, as reported from the POC data, was also measured. An additional comparison assessed the agreement between the two data sources concerning which specific drugs had been given. RESULTS: For all of the cancers, there was a high level of agreement between the Medicare claims and the POC data regarding whether or not the patient had received chemotherapy (kappa >or=0.73). The sensitivity of the Medicare data to determine if a person had received chemotherapy was high (>or=88%). In cases where the Medicare claim included a code for a specific drug, there high agreement between Medicare and POC about the specific drug given in breast and colorectal cancers, although the agreement was lower for ovarian cancers. The sensitivity of the Medicare claims to identify specific agents varies by cancer type. CONCLUSIONS: The Medicare claims can be used to identify which persons are receiving chemotherapy. The utility of Medicare data to measure treatment with specific agents varies by cancer type and specific agent. For some cancers, it is possible to use these claims to assess use of specific drugs, while for other drugs the data are limited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Do Practice Guidelines Guide Practice?
Lomas, J., Anderson, G. M., Domnick-Pierre, K., Vayda, E., Enkin, M. W., & Hannah, W. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211906 · Cited by 1,234
POTOSKY, A. L., RILEY, G. F., LUBITZ, J. D., MENTNECH, R. M., & KESSLER, L. G. (1993) · Medical Care · doi:10.1097/00005650-199308000-00006 · Cited by 694
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
Schrag, D., Cramer, L. D., Bach, P. B., & Begg, C. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.850 · Cited by 481
Who Gets Chemotherapy for Metastatic Lung Cancer?
Earle, C. C., Venditti, L. N., Neumann, P. J., Gelber, R. D., Weinstein, M. C., Potosky, A. L., & Weeks, J. C. (2000) · Chest · doi:10.1378/chest.117.5.1239 · Cited by 222
Patterns of Use of Chemotherapy for Breast Cancer in Older Women: Findings From Medicare Claims Data
Du, X., & Goodwin, J. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1455 · Cited by 172
Guadagnoli, E., Shapiro, C. L., Weeks, J. C., Gurwitz, J. H., Borbas, C., & Soumerai, S. B. (1998) · PubMed · doi:10.1002/(sici)1097-0142(19980715)83:2<302::aid-cncr14>3.0.co;2-x · Cited by 74
Studnicki, J., Schapira, D. V., Bradham, D. D., Clark, R. A., & Jarrett, A. (1993) · Cancer · Cited by 38
Cited by
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Self-citationEdwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Self-citationOwonikoko, T. K., Ragin, C. C., Belani, C. P., Oton, A. B., Gooding, W. E., Taioli, E., & Ramalingam, S. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5435 · Cited by 566
Comparison of SEER Treatment Data With Medicare Claims
Noone, A.-M., Lund, J. L., Mariotto, A., Cronin, K., McNeel, T., Deapen, D., & Warren, J. L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000073 · Cited by 488
Self-citation
Metadata
- Authors
- Warren, J. L., Harlan, L. C., Fahey, A., Virnig, B. A., Freeman, J. L., Klabunde, C. N., Cooper, G. S., & Knopf, K. B.
- Venue
- Medical Care
- Published
- 2002-08
- Volume
- 40
- Issue
- Supplement
- Pages
- IV-55-IV-61
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W4248559216
- Cited by
- 404
- References
- 7
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utility of the SEER-Medicare Data to Identify Chemotherapy Use. https://app.cochat.ai/papers/10.1097/00005650-200208001-00008
- The paper
- Warren, J. L., Harlan, L. C., Fahey, A., Virnig, B. A., Freeman, J. L., Klabunde, C. N., Cooper, G. S., & Knopf, K. B. (2002). Utility of the SEER-Medicare Data to Identify Chemotherapy Use. Medical Care. https://doi.org/10.1097/00005650-200208001-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.